Portal de Periódicos da CAPES

EXTRA‐ENDOCRINE FUNCTIONS OF VITAMIN D

1985; Wiley; Volume: 23; Issue: 4 Linguagem: Francês

10.1111/j.1365-2265.1985.tb01103.x

1365-2265

Isobel Braidman, David C. Anderson,

Diabetes Treatment and Management

Clinical EndocrinologyVolume 23, Issue 4 p. 445-460 Free Access EXTRA-ENDOCRINE FUNCTIONS OF VITAMIN D ISOBEL P. BRAIDMAN, Corresponding Author ISOBEL P. BRAIDMAN Department of Medicine (Endocrinology), Hope Hospital, (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UKIsobel P. Braidman, Department of Medicine, Hope Hospital (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UK.Search for more papers by this authorD. C. ANDERSON, D. C. ANDERSON Department of Medicine (Endocrinology), Hope Hospital, (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UKSearch for more papers by this author ISOBEL P. BRAIDMAN, Corresponding Author ISOBEL P. BRAIDMAN Department of Medicine (Endocrinology), Hope Hospital, (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UKIsobel P. Braidman, Department of Medicine, Hope Hospital (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UK.Search for more papers by this authorD. C. ANDERSON, D. C. ANDERSON Department of Medicine (Endocrinology), Hope Hospital, (University of Manchester School of Medicine), Eccles Old Road, Salford M6 8HD, UKSearch for more papers by this author First published: October 1985 https://doi.org/10.1111/j.1365-2265.1985.tb01103.xCitations: 28AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES Abe, E., Miyaura, C., Sakaganni, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S. & Suda, T. (1981) Differentiation of mouse myeloid leukemia cells induced by 1α25-dihydroxyvitamin D3. Proceedings of the National Academy of Science USA, 78, 4990–4994. Amento, E. P., Kurnick, J. T., Epstein, A. & Krane, S. M. (1982) Modulation of synovial cell products by a factor from a human cell line: T lymphocyte induction of a mononuclear cell factor. Proceedings of the National Academy of Sciences USA, 79, 5307–5311. Amento, E. P., Bhalla, A. K., Kurnick, J. T., Kradin, R. L., Clemens, T. L., Holick, S. A., Holick, M. F. & Krane, S. M. (1984) 1α25-dihydroxyvitamin D3 induces maturation of the human monocyte cell line U937 and in association with a factor from human T lymphocytes augments production of the monokine, mononuclear cell factor. Journal of Clinical Investigation, 73, 731–739. Bar Shavit, Z., Noff, D., Edelstein, S., Meyer, M., Shibolet, S. & Goldman, R. (1981) 1,25-dihydroxyvitamin D3 and the regulation of macrophage function. Calcified Tissue International, 33, 673–676. Bar Shavit, Z., Teitelbaum, S. L., Reitsma, P., Hall, A., Pegg, L. E., Trial, J. & Kahn, A. (1983) Induction of monocyte differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proceedings of the National Academy of Sciences USA, 80, 5907–5911. Bar Shavit, Z., Kahn, A. J., Reitsma, P., Trial, J., Astrin, S., Rothberg, P. & Teitelbaum S. L. (1984) 1.25 dihydroxyvitamin D3 induces monocyte differentiation and bone resorption and inhibits oncogene expression. In Endocrine Control of Bone and Calcium Metabolism, (eds D. V. Cohn, T. Fujita, J. T. Potts & R. V. Talmage) pp. 384–387. Elsevier, Amsterdam , Oxford , New York . Bhalla, A. K., Amento, E. P., Clemens, T. L., Holick, M. F. & Krane, S. M. (1983) Specific high-affinity receptors for 1.25 dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. Journal of Clinical Endocrinology and Metabolism, 57, 1308–1310. Bikle, D. (1982) Calcium transport by chick duodenal brush border membrane vesicles (BBMV). In Vitamin D, Chemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, V. D. Heath & H. G. Grigleit) pp. 314–316. de Gruyter, Berlin , New York . Braidman, I. P. & Anderson, D. C. (1984) Effects of cortisol and 1.25-dihydroxyvitamin D3 on recruitment of osteoclasts in vitro. Calcified Tissue International, 36, 511P. Braidman, I. P., Taylor, C. M. & Anderson, D. C. (1984) Evidence that 1,25-dihydroxyvitamin D3 enhances osteoclast recruitment in vitro. VIIth International Congress of Endocrinology, A42, Quebec. Breitman, T. R., Selonick, S. E. & Collins, S. J. (1980) Induction of differentiation of human promyclocytic leukemia cells (HL-60) by retinoic acid. Proceedings of the National Academy of Sciences USA, 77, 2936–2940. Brumbaugh, P. F. & Haussler, M. R. (1975) Specific binding of 1α25-dihydroxy-cholecalciferol to nuclear components of chick intestine. Journal of Biological Chemistry, 250, 1588–1594. Burger, E. H., VAN DER Meer, J. W. M., VAN DE Gevel, J. S., Gribnau, J. C., Thesingh, C. W. & VAN Furth, R. (1982) In-vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes. Journal of Experimental Medicine, 156, 1604–1614. Chen, T. L. & Feldman, D. (1981) Regulation of 1.25-dihydroxyvitamin D3 receptors in cultured mouse bone cells. Correlation of receptor concentrations with the rate of cell division. Journal of Biological Chemistry, 256, 5561–5566. Chen, T. L., Cone, C. M., Morey-Holton, E. & Feldman, D. (1982) Glucocorticoid regulation of 1,25 (OH)2-vitamin D3 receptors in cultured mouse bone cells. Journal of Biological Chemistry, 257, 13564–13569. Christakos, S., Friedlander, E. -J., Frandsen, B. R. & Norman, A. W. (1979) Studies on the mode of action of calciferol XIII. Development of a radioimmunoassay for vitamin D-dependent chick intestinal calcium-binding protein and tissue distribution. Endocrinology, 104, 1495–1503. Christakos, S. & Norman, A. W. (1979) Studies on the mode of action of calciferol XVIII. Evidence for a specific high affinity binding protein for 1,25-dihydroxyvitamin D3 in chick kidney and pancreas. Biochemical and Biophysical Research Communications, 89, 56–64. Christakos, S. & Norman, A. W. (1981) Studies of the mode of action of calciferol XXIX. Biochemical characterization of 1,25-dihydroxyvitamin D3 receptors in chick pancreas and kidney cytosol. Endocrinology. 108. Christakos, S., Bruns, M. E. H., Mehra, A. S., Rhoten, W. B. & VAN Eldik L. J. (1984) Calmodulin and rat vitamin D-dependent calcium-binding proteins. Biochemical and immunochemical comparison. Archives of Biochemistry and Biophysics, 231, 38–47. Clark, S. A., Stumpf, W. E., Sar, M., De Luca, H. F. & Tanaka, Y. (1980) Target cells for 1,25-dihydroxyvitamin D3 in the pancreas. Cell and Tissue Research, 209, 515–200. Clark, S. A., Stumpf, W. E. & Sar, M. (1981) Effect of 1,25 dihydroxyvitamin D3 on insulin secretion. Diabetes, 30, 382–386. Collins, S. J., Ruscetti, F. W., Gallagher, R. E. & Gallo, R. C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proceedings of the National Academy of Sciences USA, 75, 2458–2462. Colston, K., Hirst, M. & Feldman, D. (1980) Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology, 107, 1916–1922. Colston, K., Colston, M. J. & Feldman, D. (1981) 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology, 108, 1083–1086. Coty, W. A. (1980) A specific high affinity binding protein for 1α-25-dihydroxyvitamin D in the chick oviduct shell gland. Biochemical and Biophysical Research Communications, 93, 285–292. De Luca, H. F. (1979a) Recent advances in our understanding of the vitamin D-endocrine system. Journal of Steroid Biochemistry, 11, 35–54. De Luca, H. F. (1979b) The Vitamin D system in the regulation of calcium and phosphorus metabolism. Nutritional Reviews, 37, 161–193. Dodd, R. C., Newman, S. L., Winkler, C. F., Bunn, P. A., Cohen, M. S. & Gray, T. K. (1984) Lymphokine-mediated differentiation of osteoclast precursors. A comparison of interleukin 2, γ interferon and α interferon. Calcified Tissue International, 366, 457P. Edwards, D. J., Rimmer, J. J., Atkinson, M. J. & Perris, A. D. (1981) Changes in plasma levels of calcium and in bone marrow mitosis after antigenic challenge in rats and mice. Journal of Endocrinology, 90, 445–452. Eisman, J. A., Martin, T. J., MacIntyre, I. & Moseley, J. M. (1979) 1,25-dihydroxyvitamin-D receptor in breast cancer cells. Lancet, ii, 1335–1336. Emtage, J. S., Lawson, D. E. M. & Kodicek, E. (1973) Vitamin D-induced synthesis of mRNA for calcium-binding protein. Nature, 246, 100–101. Feldman, D., Chen, T., Hirst, M., Colston, K., Karasek, M. & Cone, C. (1980) Demonstration of 1,25-dihydroxyvitamin D3 receptors in human skin biopsies. Journal of Clinical Endocrinology and Metabolism, 51, 1463–1465. Frampton, R. J., Suva, L. J., Eisman, J. A., Findlay, D. M., Moore, G. E., Moseley, J. M. & Martin, T. J. (1982) Presence of 1,25-dihydroxyvitamin D3 in established human cell lines in culture. Cancer Research, 42, 1116–1119. Franceschi, R. T. (1984) Interaction of the 1α25-dihydroxyvitamin D3 receptor with RNA and synthetic polyribonucleotides. Proceedings of the National Academy of Sciences USA, 81, 2337–2341. Freake, H. C., Marocci, C., Iwasaki, J. & MacIntyre, I. (1981) 1,25-dihydroxyvitamin D3 specifically binds to a human breast cancer line (T4 7D) and stimulates growth. Biochemical and Biophysical Research Communications, 101, 1131–1138. Friedlander, E. J., Henry, H. L. & Norman, A. W. (1977) Studies of the mode of action of calciferol. Effects of dietary calcium and phosphorus on the relationships between the 25 dihydroxyvitamin D3-1-α hydroxylase and production of chick intestinal calcium binding protein. Journal of Biological Chemistry, 252, 8677–8683. Gillis, S. (1983) Interleukin biochemistry and biology. Federation Proceedings, 42, 2635–2638. Gowen, M., Wood, D. D., Ihrie, E. J., McGuire, M. K. B. & Russell, R. G. G. (1983) An interleukin 1-like factor stimulates bone resorption in vitro. Nature, 306, 378–380. Haug, E., Pedersen, J. I. & Gautvik, K. (1982) Effects of vitamin D metabolites on prolactin and growth hormone synthesis in cultured rat pituitary cells. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit) pp. 87–89. de Gruyter, Berlin , New York . Haussler, M. R. (1974) Vitamin D: mode of action and biomedical applications. Nutritional Reviews, 32, 257–266. Haussler, M. R. & McCain, T. A. (1977a) Basic and clinical concepts related to vitamin D metabolism and action (part 1). New England Journal of Medicine, 297, 974–983. Haussler, M. R. & McCain, T. A. (1977b) Basic and clinical concepts related to vitamin D metabolism and action (part 2). New England Journal of Medicine, 297, 1041–1050. Haussler, M. R., Manolagas, S. C. & Deftos, L. J. (1980) Evidence for a 1,25-dihydroxyvitamin D3 receptor-like macromolecule in rat pituitary. Journal of Biological Chemistry, 255, 5007–5010. Haussler, M. R., Pike, J. W., Dokoh, S., Chandler, J. S., Chandler, S. K., Donaldson, C. A. & Marion, S. L. (1982) 1,25-dihydroxyvitamin D3 receptor in cultured cell lines: occurrence subcellular distribution and relationship to bioresponses. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Guigoleit). pp. 109–114. de Gruyter, Berlin , New York . Henry, H. L. (1979) Regulation of the hydroxylation of 25-hydroxyvitamin D3 in vivo and in primary cultures of chick kidney cells. Journal of Biological Chemistry, 254, 2722–2729. Hodler, B., Evequoz, V., Trechsel, U. & Fleisch, H. (1984) 1,25(OH)2D3 enhances production of interleukines (IL1) by P388D1 macrophages and of IL3 of WEHI-3 cells but decreases IL2 release by rat spleen cells. Calcified Tissue International, 366, 461P. Holtrop, M. E., Co, K. A., Clark, M. B., Holick, M. F. & Anast, C. S. (1981) 1,25 dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology, 108, 2293–2301. Honma, Y., Kasukabe, T., Okabe, J. & Hozumi, M. (1977) Glucocorticoid binding and mechanism of resistance in some clones of mouse myeloid leukemic cells, resistant to induction of differentiation by dexamethasone. Journal of Cell Physiology, 93, 227–236. Honma, Y., Hozumi, M., Abe, E., Konno, K., Fukushima, M., Huta, S., Nishii, Y., De Luca, H. F. & Suda, T. (1983) 1α25-dihydroxyvitamin D3 and 1α-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells. Proceedings of the National Academy of Science USA, 80, 201–204. Howard, G. A., Turner, R. T., Sherrard, D. J. & Baylink, D. J. (1981) Human bone cells in culture metabolise 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Journal of Biological Chemistry, 256, 7738–7740. Hunt, N. H. & Perris, A. D. (1974) Calcium and the control of circadian mitotic activity in rat bone marrow and thymus. Journal of Endocrinology, 56, 47–57. Jande, S. S., Schreiner, D. S. & Lawson, D. E. M. (1982) Cellular localisation of vitamin D dependent calcium binding protein by immunoperoxidase methods. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (ed A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 203–208. de Gruyter. Berlin , New York . Kawashima, H. & Kurokawa, K. (1982) Localization of 1,25-dihydroxyvitamin D3 receptors for the presence of specific binding in both proximal and distal nephcon. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 95–96. de Gruyter, Berlin , New York . Klaus, G. G. B. & Hawrylowicz, C. M. (1984) Cell cycle control in lymphocyte stimulation. Immunology Today, 5, 15–19. Krane, S. C. (1984) Workshop—Lymphokines and immune cell-derived growth factor, 6th Annual Scientific Meeting of the American Society for Bone and Mineral Research, June 1984.. Kream, B. E., Jose, M., Yamada, S. & De Luca, H. F. (1977a) A specific high affinity binding macromolecule for 1,25-dihydroxyvitamin D3 in fetal bone. Science, 197, 1086–1088. Kream, B. E., Yamada, S., Schnoes, H. K. & De Luca, H. F. (1977b) Specific cytosolic-binding protein for 1,25-dihydroxyvitamin D3 in rat intestine. Journal of Biological Chemistry, 252, 4501–4505. Lachman, L. B. (1983) Human interleukin 1: purification and properties. Federation Proceedings, 42, 2639–2645. Lawson, D. E. M., Jande, S. S., Sandhu, J. S. & Schreiner, D. S. (1984) Aspects of 1,25 (OH)2D3 function in cells. In Endocrine Control of Bone and Calcium Metabolism, (eds D. V. Cohn, T. Fujita, J. T. Potts & R. V. Talmage), pp. 301–307. Elsevier, Amsterdam , New York , Oxford . Lenzen, S. & Klöppel, G. (1984) Intracellular localization of calcium in pancreatic B cells in relation to insulin secretion by perfused ob ob mouse. Endocrinology, 114, 1012–1020. Liberman, U. A., Eil, C. & Marx, S. J. (1982) Defects in target tissue response to 1,25-dihydroxyvitamin D3 (1.25 (OH)2D3). Evaluation of cellular basis with cultured skin fibroblasts. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 73–78. de Gruyter, Berlin , New York . Mahgoub, A. & Shepherd, H. (1977) Effect of hydroxyvitamin D3 derivatives on 45Ca release from rat fetal bones in vitro. Endocrinology, 100, 629–635. Malaisse-Lagae, F., Mathias, P. C. F. & MaLaisse, W. J. (1984) Gating and blocking of calcium channels by dihydroxypyridines in the pancreatic B-cell. Biochemical and Biophysical Research Communications, 123, 1062–1067. Manolagas, S. C., Taylor, C. M. & Anderson, D. C. (1979a) Highly specific binding of 1,25-dihydroxychole-calciferol in bone cytosol. Journal of Endocrinology, 80, 35–39. Manolagas, S. C., Anderson, D. C. & Lumb, G. A. (1979b) Glucocorticoids regulate concentration of 1,25-dihydroxycholecalciferol receptors in bone. Nature, 277, 314–315. Manolagas, S. C., Haussler, M. R. & Deftos, L. J. (1980) 1.25-dihydroxyvitamin D3 receptor-like macromolecule in rat osteogenic sarcoma cell lines. Journal of Biological Chemistry, 255, 4414–4417. Manolagas, S. C. & Deftos, L. J. (1984) The vitamin D endocrine system and the hematolymphopoietic tissue. Annals of Internal Medicine, 100, 144–146. Manolagas, S. C., Abare, J. & Deftos, L. J. (1984a) Glucocorticoids increase the 1.25(OH)2D3 receptor concentrations in rat osteogenic sarcoma cells. Calcified Tissue International, 36, 153–157. Manolagas, S. C., Provvedini, D. M., Tsoukos, C. D. & Deftos, L. J. (1984b) 1.25 (OH)2D3 receptors and effects on leukocytes: novel evidence for an immunoregulatory role of the hormone. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 338–341. de Gruyter, Berlin , New York . Mason, R. S., Frankel, T., Chen, Y. L., Lissner, D. & Posen, S. (1984) Vitamin D conversion by sarcoid lymph node homogenate. Annals of Internal Medicine, 100, 59–61. Mellon, W. S. & De Luca, H. F. (1980) A specific dihydroxyvitamin D3 binding macromolecule in chicken bone. Journal of Biological Chemistry, 255, 4081–4086. Miyaura, C, Abe, E., Kuibayashi, T., Tanaka, H., Konno, K., Nishii, Y. & Suda, T. (1981) 1α25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochemical and Biophysical Research Communications, 102, 937–943. Miyaura, C., Abe, E., Honma, Y., Hozumi, M., Nishii, Y. & Suda, T. (1983) Cooperative effect of 1α25-dihydroxyvitamin D3 and dexamethasone in inducing differentiation of mouse myeloid leukemia cells. Archives of Biochemistry and Biophysics, 227, 379–385. Mudher, S., Braidman, I. P., Hales, M. & Anderson, D. C. (1982) Comparison of binding of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in intact tissue and cytosol preparations from bone and other tissues in the fetal rat. Journal of Endocrinology, 92, 147–155. Mulkins, M. A., Manolagas, S. C., Deftos, L. J. & Sussman, H. H. (1983) 1,25-dihydroxyvitamin D3 increases bone alkaline phosphatase isoenzyme levels in human osteogenic sarcoma cells. Journal of Biological Chemistry, 258, 6219–6225. Murdoch, G. H. & Rosenfeld, M. G. (1981) Regulation of pituitary function and prolactin production in the GH4 cell line by Vitamin D. Journal of Biological Chemistry, 256, 4050–4055. Narbaitz, R., Stumpf, W. E., Sar, M., Huang, S. & De Luca, H. F. (1983) Autoradiographic localisation of target cells for 1α25-dihydroxyvitamin D3 in bones from fetal rats. Calcified Tissue International, 35, 177–182. Nijweide, P., VAN DER Plas, A. & Vrijheid-Lammers, T. (1984) Production of monoclonal antibodies specific for osteoclasts. Calcified Tissue International, 366, 466P. Norman, A. W., Frankel, B. J., Heldt, A. M. & Grodsley, G. M. (1980) Vitamin D deficiency inhibits pancreatic secretion of insulin. Science, 209, 823–825. Norman, A. W., Roth, J. & Orci, L. (1982) The vitamin D endocrine system: steroid metabolism, hormone receptors and biological response (calcium binding proteins). Endocrine Reviews, 3, 331–336. Okabe, T., Ishizuka, S., Fujisawa, M., Watanabe, J. & Takaku, F. (1984) Sarcoid granulomas metabolise 25-hydroxyvitamin D3. Biochemical and Biophysical Research Communications, 123, 822–831. Peacock, M., Jones, S., Clemens, T. L., Amento, E. P., Kurnick, J., Krane, S. M. & Holick, M. F. (1982) High affinity 1,25(OH)2D3 Vitamin D3 receptors in a human monocyte like cell line (U937) and in a cloned human T lymphocyte. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism, (eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 83–85. de Gruyter, Berlin , New York . Provvedini, D. M., Tsoukos, C. D., Deftos, L. J. & Manolagas, S. C. (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science, 221, 1181–1183. Provvedini, D. M., Deftos, L. J. & Manolagas, S. C. (1984) 1,25-dihydroxyvitamin D3 receptors in a subset of mitotically active lymphocytes from rat thymus. Biochemical and Biophysical Research Communications, 121, 277–283. Raisz, L. G., Trummel, C. L., Holick, M. F. & De Luca, H. F. (1972) 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science, 175, 768–769. Rasmussen, H., Fontaine, O., Max, E. E. & Goodman, D. B. P. (1979) The effect of 1αhydroxyvitamin D3 administration on calcium transport in chick intestine brush border membrane vesicles. Journal of Biological Chemistry, 254, 2993–2999. Ravid, A., Koren, R., Novogrodsky, A. & Liberman, U. A. (1984) 1,25-dihydroxyvitamin D3 inhibits selectively the mitogenic stimulation of mouse medullary thymocytes. Biochemical and Biophysical Research Communications, 123, 163–169. Reitsma, P. H., Rothberg, P. G., Astrin, S. M., Trial, J., Bar-Shavit, Z., Hall, A., Teitelbaum, S. L. & Kahn, A. J. (1983) Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature, 306, 492–494. Reynolds, J. J., Holick, M. F. & De Luca, H. F. (1973) The role of vitamin D metabolites in bone resorption. Calcified Tissue Research, 12, 295–301. Robb, R. J. (1984) Interleukin 2: the molecule and its function. Immunology Today, 5, 203–209. Roth, J., Thoreus, B., Brown, D., Baeteus, D., Garcia-Segura, L. M., Norman, A. W. & Orci, L. (1982a) Immunocytochemical localization of vitamin D-dependent calcium binding protein (CaBP) in duodenum, kidney, brain and pancreas. In Vitamin D, Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism (Eds A. W. Norman, K. Schaefer, D. V. Herrath & H. -G. Grigoleit), pp. 209–214. de Gruyter, Berlin , New York . Roth, J., Bonner-West, S., Norman, A. W. & Orci, L. (1982b) Immunocytochemistry of Vitamin D-dependent calcium binding protein in chick pancreas: exclusive localization in B-cells. Endocrinology, 110, 2216–2218. Rovera, G., Santoli, D. & Damsky, C. (1979) Human promyelocytic cells in culture differentiate into macrophage-like cells when treated with a phorbol ester. Proceedings of the National Academy of Sciences USA, 76, 2779–2783. Sher, E., Eisman, J. A., Moseley, J. M. & Martin, T. J. (1981) Whole-cell uptake and nuclear localisation of 1,25-dihydroxycholecalciferol by breast cancer cells (T47D) in culture. Biochemical Journal, 200, 315–320. Simpson, R. U. & De Luca, H. F. (1980) Characterisation of a receptor-like protein for 1,25-dihydroxyvitamin D3 in rat skin. Proceedings of the National Academy of Sciences USA, 77, 5822–5826. Strauss, D. S. (1984) Growth stimulatory actions of insulin in vitro and in vivo. Endocrine Reviews, 5, 356–369. Stumpf, W. E., Sar, M., Reid, F. A., Tanaka, Y. & De Luca, H. F. (1979) Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary and parathyroid. Science, 206, 1188–1190. Suda, T., Abe, E., Miyaura, C., Tanaka, H., Shiina, Y., Kuribayashi, T., Honma, Y., Hozumi, M., Momoi, T. & Nishiy (1984) Does Vitamin D have a specific role in cell growth and differentiation? In Endocrine Control of Bone and Calcium Metabolism Vol 8, (ed D. V. Cohn, T. Fujita, J. T. Potts & R. V. Talmage) pp. 308–315. Excerpta Medica, Amsterdam , New York , Oxford . Sundström, C. & Nilsson, K. (1976) Establishment and characterisation of a human histiocytic lymphoma cell line (U937). International Journal of Cancer, 17, 565–577. Tanaka, H., Abe, E., Miyaura, C., Kuribayashi, T., Konno, K., Nishii, Y. & Suda, T. (1982) 1α25-dihydroxycholecalciferol and a Human myeloid leukaemia cell line. Biochemical Journal, 204, 713–719. Tsai, H. C., Wong, R. G. & Norman, A. W. (1972) Studies on calciferol metabolism; subcellular localisation of 1,25-dihydroxyvitamin D3 in intestinal mucosa and correlation with increased calcium transport. Journal of Biological Chemistry, 247, 5511–5519. Turner, R. T., Puzas, J. E., Forte, M., Lester, G. E., Gray, T. K., Howard, G. A. & Baylink, D. J. (1980) In-vitro synthesis of 1α25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proceedings of the National Academy of Sciences USA, 77, 5720–5724. Valesquez, M. J., Bell, L. & Osdoby, P. (1984) Immuno-histochemical and biochemical analysis of osteoclast specific monoclonal antibodies. Calcified Tissue International, 366, 474P. Walters, M. R. (1981) An estrogen-stimulated 1,25-dihydroxyvitamin D3 receptor in rat uterus. Biochemical and Biophysical Research Communications, 103, 721–726. Walters, M. R., Rosen, D. M., Norman, A. W. & Luben, R. A. (1982) 1,25-dihydroxyvitamin D3 receptors in an established bone cell line. Journal of Biological Chemistry, 257, 7481–7484. Wark, J. D. & Tashjian, A. H. (1982) Vitamin D stimulates prolactin synthesis by GH4C1 cells incubated in chemically defined medium. Endocrinology, 111, 1755–1757. Wasserman, R. H. & Taylor, A. N. (1966) Vitamin D-induced calcium-binding protein in chick intestinal mucosa. Science, 152, 791–793. Wecksler, W. R. & Norman, A. W. (1980) A kinetic and equilibrium binding study of 1α25-dihydroxyvitamin D3 with its cytosol receptor from chick intestinal mucosa. Journal of Biological Chemistry, 255, 3571–3574. Wecksler, W. R., Ross, F. P. & Norman, A. W. (1979a) Characterization of the 1α25-dihydroxyvitamin D3 receptor from intestinal cytosol. Journal of Biological Chemistry, 254, 9488–9491. Wecksler, W. R., Mason, R. S. & Norman, A. W. (1979b) Specific cytosol receptors for 1,25-dihydroxyvitamin D3 in human intestine. Journal of Clinical Endocrinology and Metabolism, 48, 715–717. Wecksler, W. R., Ross, F. P., Mason, R. S., Posen, S. & Norman, A. W. (1980) Biochemical properties of the 1α25-dihydroxyvitamin D3 cytoplasmic receptors from human and chick parathyroid glands. Archives Biochemistry and Biophysics, 201, 95–103. Wiedenkeller, D. E. & Sharp, G. W. G. (1984) Unexpected potentiation of insulin release by the calcium store blocker TMB-8. Endocrinology, 114, 116–119. Yen, A. & Albright, K. L. (1984) Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake. Cancer Research, 44, 2511–2515. Citing Literature Volume23, Issue4October 1985Pages 445-460 ReferencesRelatedInformation